Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction: The Framingham Heart Study

Applied logistic regression

(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305

The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856

Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Sahn, D. J., DeMaria, A. N., KISSLO, J. A., & Weyman, A. E. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

Hanley, J. A., & McNeil, B. J. (1983) · Radiology · doi:10.1148/radiology.148.3.6878708 · Cited by 7,016

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial

Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study

Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777

Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions

(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725

Users' Guides to the Medical Literature

Jaeschke, R. (1994) · JAMA · doi:10.1001/jama.271.9.703 · Cited by 2,688

AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES

Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639

Echocardiography and carotid intima–media thickness among asymptomatic HIV-infected adolescents in Thailand

Chanthong, P., Lapphra, K., Saihongthong, S., Sricharoenchai, S., Wittawatmongkol, O., Phongsamart, W., Rungmaitree, S., Kongstan, N., & Chokephaibulkit, K. (2014) · AIDS · doi:10.1097/qad.0000000000000376 · Cited by 26

Genetic Ablation and Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Impact on the Pathophysiology of Cardiovascular Dysfunction

Pandey, K. N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163946 · Cited by 26

AI-enabled cardiac chambers volumetry in coronary artery calcium scans (AI-CACTM) predicts heart failure and outperforms NT-proBNP: The multi-ethnic study of Atherosclerosis

Naghavi, M., Reeves, A. P., Budoff, M. J., Li, D., Atlas, K., Zhang, C., Atlas, T., Roy, S. K., Henschke, C. I., Wong, N. D., et al. (2024) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2024.04.006 · Cited by 27

Real-time RT-PCR for gene expression profiling in blood of heart failure patients?A pilot study

Stypmann, J., Breithardt, G., Schulze‐Bahr, E., & Seiler, P. (2004) · Basic Research in Cardiology · doi:10.1007/s00395-004-0467-6 · Cited by 25

Biomarkers in metabolic syndrome

Cho, Y. H., Lee, Y., Choi, J. I., Lee, S. R., & Lee, S. Y. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.07.003 · Cited by 25

Association of Cardio-Ankle Vascular Index with Brain Natriuretic Peptide Levels in Hypertension

Masugata, H., Senda, S., Inukai, M., Murao, K., Himoto, T., Hosomi, N., Murakami, K., Noma, T., Kohno, M., Okada, H., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10314 · Cited by 24

Substantial intraindividual variability of BNP concentrations in patients with hypertension

Conen, D., Pfisterer, M. E., & Martina, B. E. E. (2006) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001988 · Cited by 24

NT-ProBNP in Outpatients After Myocardial Infarction: Interaction Between Symptoms and Left Ventricular Function and Optimized Cut-Points

Luchner, A., Hengstenberg, C., Löwel, H., Büchner, S., Schunkert, H., Riegger, G. A. J., & Holmer, S. R. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.04.018 · Cited by 24

Value of N-Terminal Pro Brain Natriuretic Peptide in the Elderly: Data from the Prospective Copenhagen Hospital Heart Failure Study (CHHF)

Nielsen, O. W., Kirk, V., Bay, M., Boesgaard, S., & Nielsen, H. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2003.12.010 · Cited by 24

Biomarkers in heart failure: a clinical review

Rocchiccioli, P., McMurray, J. J. V., & Dominiczak, A. F. (2008) · Heart Failure Reviews · doi:10.1007/s10741-008-9123-9 · Cited by 23

Risk scores versus natriuretic peptides for identifying prevalent stage B heart failure

Gupta, S., Rohatgi, A. K., Ayers, C. R., Patel, P. C., Matulevicius, S. A., Peshock, R. M., Markham, D. W., de Lemos, J. A., Berry, J. D., & Drazner, M. H. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.01.007 · Cited by 24

Assessment of left ventricular function by CMR versus MUGA scans in breast cancer patients receiving trastuzumab: a prospective observational study

Dhir, V., Yan, A. T.-K., Nisenbaum, R. A., Sloninko, J., Connelly, K. A., Barfett, J., Haq, R., Kirpalani, A., Chan, K., Petrella, T. M., et al. (2019) · International journal of cardiac imaging · doi:10.1007/s10554-019-01648-z · Cited by 23

The Increasing Impact of Laboratory Medicine on Clinical Cardiology

Clerico, A. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.132 · Cited by 23

Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care

Hill, S., Balion, C. M., Santaguida, P. L., McQueen, M., Ismaila, A., Reichert, S. M., McKelvie, R. S., Worster, A., & Raina, P. S. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.08.016 · Cited by 23

International Society for Heart and Lung Transplantation Developed in Collaboration With the Force on Practice Guidelines: American College of Cardiology Foundation/American Heart Association Task Diagnosis and Management of Heart Failure in Adults: A Report of the 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the

Stevenson, W., Yancy, C. W., Mancini, M. E., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Francis, S. A., Ganiats, T. G., Jessup, M. L., et al. (2009) · Cited by 22

The use of blood biomarkers in precision medicine for the primary prevention of atherosclerotic cardiovascular disease: a review

Sweeney, T. E., Quispe, R., Das, T. M., Juraschek, S. P., Martin, S. S., & Michos, E. D. (2021) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2021.1930531 · Cited by 24

N-terminal pro-brain natriuretic peptide – a promising biomarker for the diagnosis of left ventricular hypertrophy in hypertensive women

Mouly-Bertin, C., Bissery, A., Milon, H., Dzudié, A., Rabilloud, M., Bricca, G., Vincent, M., & Lantelme, P. (2008) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2008.04.007 · Cited by 22

Urinary B-Type Natriuretic Peptide Levels in the Diagnosis and Prognosis of Heart Failure

Cortés, R., Rivera, M., Salvador, A., de Burgos, F. G., Bertoméu, V., Roselló‐Lletí, E., Martínez‐Dolz, L., Payá, R., Almenar, L., & Portolés, M. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.04.007 · Cited by 22

B-Type Natriuretic Peptides and Their Relation to Cardiovascular Structure and Function in a Population-Based Sample of Subjects Aged 70 Years

Eggers, K. M., Lindahl, B., Venge, P., & Lind, L. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.12.014 · Cited by 21

Screening to Prevent Heart Failure (STOP-HF): Expanding the Focus Beyond Asymptomatic Left Ventricular Systolic Dysfunction

Murtagh, G., Dawkins, I. R., O’Connell, P. R., Badabhagni, M., Patel, A. S., Tallon, E., O’Hanlon, R., Ledwidge, M. T., & McDonald, K. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs030 · Cited by 21

Diagnostic accuracy and clinical relevance of brain natriuretic peptide assay in pediatric patients with congenital heart diseases

Cantinotti, M., Vittorini, S., Storti, S., Prontera, C., Murzi, M., Lucia, V. D., Recla, S., Assanta, N., Giusti, S., Murzi, B., et al. (2009) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32832c15fb · Cited by 21

Utilidad del NT-proBNP en el diagnóstico de la hipertrofia ventricular izquierda en el paciente hipertenso. Estudio mediante resonancia cardiaca

Morillas, P., Castillo, J., Quiles, J., Núñez, D., Guillén, S., Maceira, A. M., Rivera, M., & Bertomeua, V. (2008) · Revista Española de Cardiología · doi:10.1157/13125520 · Cited by 21

Biomarkers of Left Ventricular Hypertrophy and Remodeling in Blacks

Coutinho, T. A., Al-Omari, M. A., Mosley, T. H., & Kullo, I. J. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.178095 · Cited by 21

The Effect of Diabetes on B-Type Natriuretic Peptide Concentrations in Patients With Acute Dyspnea

Wu, A. H. B., Omland, T., Duc, P., McCord, J., Nowak, R. M., Hollander, J. E., Herrmann, H. C., Steg, P. G., Knudsen, C. W., Storrow, A. B., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2398 · Cited by 21

Aortic Stiffness Is an Independent Determinant of B-Type Natriuretic Peptide in Patients with Coronary Artery Disease

Sakuragi, S., Okawa, K., Iwasaki, J., Tokunaga, N., Kakishita, M., & Ohe, T. (2006) · Cardiology · doi:10.1159/000094720 · Cited by 20

The Association Between Alcohol Consumption and Left Ventricular Ejection Fraction

Zhao, L., Guo, X., Bai, Y., Sun, G., Guan, Y., Sun, Y., & Roselle, A. M. (2016) · Medicine · doi:10.1097/md.0000000000003763 · Cited by 20

Ideal cardiovascular health and the subclinical impairments of cardiovascular diseases: a cross-sectional study in central south China

Wang, Y., Wang, C., Zhu, L., Yuan, H., Wu, L., & Chen, Z. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0697-9 · Cited by 20

Plasma NT‐proBNP concentration is related to ambulatory pulse pressure in peripheral arterial disease

Svensson, P., Fairé, U. D., Niklasson, U., Hansson, L., & Östergren, J. (2005) · Blood Pressure · doi:10.1080/08037050510008931 · Cited by 20

Correlation between B-Type Natriuretic Peptide and Functional/Cognitive Parameters in Discharged Congestive Heart Failure Patients

Leto, L., Testa, M., & Feola, M. (2015) · International Journal of Endocrinology · doi:10.1155/2015/239136 · Cited by 19

The relationship between the level of plasma B-type natriuretic peptide and mitral stenosis

Eryol, N. K., Doğan, A., Özdoğru, İ., İnanç, M. T., Kaya, M. G., & Kalay, N. (2006) · International journal of cardiac imaging · doi:10.1007/s10554-006-9174-8 · Cited by 19

Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients

Ravassa, S., Beloqui, Ó., Varo, N., Barba, J., López, B., Beaumont, J., Zalba, G., Dı́ez, J., & González, A. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835ca903 · Cited by 19

Relation of N-Terminal Pro-B-Type Natriuretic Peptide With Diastolic Function in Hypertensive Heart Disease

Uraizee, I., Cheng, S. C., Hung, C.-L., Verma, A., Thomas, J. D., Zile, M. R., Aurigemma, G. P., & Solomon, S. D. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt098 · Cited by 19

Polycystin 2-dependent cardio-protective mechanisms revealed by cardiac stress

Giehl, E., Lemos, F. O., Huang, Y., Giordano, F. J., Kuo, I. Y., & Ehrlich, B. E. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-2042-7 · Cited by 19

Hipertensión y valores de NT-proBNP. Su importancia en el diagnóstico de insuficiencia cardíaca

Rivera, M., Taléns‐Visconti, R., Salvador, A., Bertoméu, V., Miró, V., de Burgos, F. G., Climent, V. E., Cortés, R., Payá, R., Pérez-Boscá, J. L., et al. (2004) · Revista Española de Cardiología · doi:10.1016/s0300-8932(04)77124-9 · Cited by 19

Comprehensive Review of the Relative Clinical Utility of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide Assays in Cardiovascular Disease

McCullough, P. A., & Neyou, A. (2009) · Open Heart Failure Journal · doi:10.2174/1876535100902010006 · Cited by 19

Amino-Terminal Pro–B-Type Natriuretic Peptide Testing in Patients with Diabetes Mellitus and with Systemic Hypertension

Hildebrandt, P. R., & Richards, M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.015 · Cited by 19

AI-Enabled CT Cardiac Chamber Volumetry Predicts Atrial Fibrillation and Stroke Comparable to MRI

Naghavi, M., Reeves, A. P., Atlas, K. C., Zhang, C., Li, D., Atlas, T. L., Henschke, C. I., Wong, N. D., Roy, S. K., Budoff, M. J., et al. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101300 · Cited by 18

Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV

Dirajlal‐Fargo, S., Kinley, B., Jiang, Y., Longenecker, C. T., Hileman, C. O., Debanne, S. M., & McComsey, G. A. (2014) · AIDS · doi:10.1097/qad.0000000000000547 · Cited by 18

Natriuretic Peptide Testing in Primary Care

Rehman, S., & Januzzi, J. L. (2008) · Current Cardiology Reviews · doi:10.2174/157340308786349499 · Cited by 18

Cardiac troponin I measured with a very high sensitivity assay predicts subclinical carotid atherosclerosis: The Akershus Cardiac Examination 1950 Study

Lyngbakken, M. N., Vigen, T., Ihle‐Hansen, H., Brynildsen, J., Berge, T., Rønning, O. M., Tveit, A., Røsjø, H. R., & Omland, T. (2021) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2021.04.005 · Cited by 18

Early diagnosis of congestive heart failure: clinical utility of B-type natriuretic peptide testing associated with Doppler echocardiography

Aspromonte, N., Feola, M., Scardovi, A. B., Coletta, C., DʼEri, A., Giovinazzo, P., Carunchio, A., Chiera, A., Fanelli, R., Giacomo, T. D., et al. (2006) · Journal of Cardiovascular Medicine · doi:10.2459/01.jcm.0000228690.40452.d3 · Cited by 18

Management of diastolic heart failure - a practical review of pathophysiology and treatment trial data

Wu, E. B., & Yu, C. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00642.x · Cited by 18

Brain natriuretic peptide detects cardiac abnormalities in mass screening

Takase, H., Toriyama, T., Sugiura, T., Takahashi, A., Sugiyama, M., Ohashi, M., Ueda, R., & Dohi, Y. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01780.x · Cited by 18

The Use of Brain Natriuretic Peptide in the Evaluation of Heart Failure in Geriatric Patients

Marinescu, M. C., Oprea, V. D., Nechita, A., Tutunaru, D., Nechita, L., & Romila, A. (2023) · Diagnostics · doi:10.3390/diagnostics13091512 · Cited by 17

AI-enabled left atrial volumetry in coronary artery calcium scans (AI-CACTM) predicts atrial fibrillation as early as one year, improves CHARGE-AF, and outperforms NT-proBNP: The multi-ethnic study of atherosclerosis

Naghavi, M., Yankelevitz, D. F., Reeves, A. P., Budoff, M. J., Li, D., Atlas, K. C., Zhang, C., Atlas, T. L., Lirette, S. T., Wasserthal, J., et al. (2024) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2024.04.005 · Cited by 17

Early detection and significance of structural cardiovascular abnormalities in patients with Type 2 diabetes mellitus

Somaratne, J., WHALLEY, G. A., Bagg, W., & Doughty, R. N. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.1.109 · Cited by 15

Using BNP to develop a risk score for heart failure in primary care

Adlam, D., Silcocks, P., & Sparrow, N. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi178 · Cited by 17

Epidemiologie der linksventrikul�ren systolischen Dysfunktion in der Allgemeinbev�lkerung Deutschlands

Fischer, M., Baessler, A., Holmer, S. R., Muscholl, M. W., Br�ckel, U., Luchner, A., Hense, H., D�ring, A., Riegger, G. A. J., & Schunkert, H. (2003) · Zeitschrift für Kardiologie · doi:10.1007/s00392-003-0899-2 · Cited by 17

Artificial intelligence-enhanced six-lead portable electrocardiogram device for detecting left ventricular systolic dysfunction: a prospective single-centre cohort study

Lim, J., Lee, H. S., Han, G. I., Kang, S., Jang, J.-H., Jo, Y., Son, J. M., Lee, M. S., Kwon, J., & Lee, S. (2025) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztaf025 · Cited by 16

Skin autofluorescence is associated with high-sensitive cardiac troponin T, a circulating cardiac biomarker, in Japanese patients with diabetes: A cross-sectional study

Yoshioka, K. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118785314 · Cited by 16

Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024

Chinese Society of Cardiology, C. M. A., Chinese College of Cardiovascular Physician, Chinese Heart Failure Association of Chinese Medical Doctor Association, & Editorial Board of Chinese Journal of Cardiology (2025) · Cardiology Discovery · doi:10.1097/cd9.0000000000000146 · Cited by 17

Natriuretic Peptides and Echocardiography in Acute Dyspnoea: Implication of Elevated Levels with Normal Systolic Function

Shah, K. B., Kop, W. J., Christenson, R. H., Diercks, D. B., Kuo, D. C., Henderson, S., Hanson, K., Li, S.-Y., & deFilippi, C. R. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp075 · Cited by 16

Péptidos natriuréticos en insuficiencia cardiaca

Bonet, L. A., & Martínez‐Dolz, L. (2006) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(06)74831-2 · Cited by 16

Utility of Brain Natriuretic Peptide (BNP) Measurement in Cardiovascular Disease

SULLIVAN, D. R., West, M., & Jeremy, R. (2005) · Heart Lung and Circulation · doi:10.1016/j.hlc.2005.03.002 · Cited by 16

Artificial intelligence-enabled electrocardiographic screening for left ventricular systolic dysfunction and mortality risk prediction

Huang, Y., Hsu, Y.-C., Liu, Z., Lin, C., Tsai, R., Chen, J., Chang, P., Liu, H.-T., Lee, W.-C., Wo, H.-T., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1070641 · Cited by 17

Heart Failure: Etiology and Approach to Diagnosis

Segovia, J., Rivera, L. A.-P., Moral, R. P., & Melchor, L. S. (2004) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60143-6 · Cited by 17

Circulating microRNAs to predict heart failure after acute myocardial infarction in women

Lalem, T., & Devaux, Y. (2019) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2019.05.011 · Cited by 15

ECG Indices Poorly Predict Left Ventricular Hypertrophy and Are Applicable Only in Individuals with Low Cardiovascular Risk

Chlabicz, M., Jamiołkowski, J., Paniczko, M., Sowa, P., Szpakowicz, M., Łapińska, M., Jurczuk, N., Kondraciuk, M., Ptaszyńska‐Kopczyńska, K., Raczkowski, A., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051364 · Cited by 15

The role of b-type natriuretic peptide in heart failure management

Newton, P. J., Betihavas, V., & Macdonald, P. S. (2009) · Australian Critical Care · doi:10.1016/j.aucc.2009.06.001 · Cited by 15

NT-proBNP Levels and Hypertension. Their Importance in the Diagnosis of Heart Failure

Rivera, M., Taléns‐Visconti, R., Salvador, A., Bertoméu, V., Miró, V., de Burgos, F. G., Climent, V. E., Cortés, R., Payá, R., Pérez-Boscá, J. L., et al. (2004) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60170-9 · Cited by 15

Usefulness of NT-proBNP Level for Diagnosing Left Ventricular Hypertrophy in Hypertensive Patients. A Cardiac Magnetic Resonance Study

Morillas, P., Castillo, J., Quiles, J., Núñez, D., Guillén, S., Maceira, A. M., Rivera, M., & Bertoméu, V. (2008) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(08)60259-5 · Cited by 15

Impact of Epitope Specificity and Precursor Maturation in Pro-B–Type Natriuretic Peptide Measurement

Goetze, J. P., Dahlström, U., Rehfeld, J. F., & Alehagen, U. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105635 · Cited by 14

Implications of the ACC/AHA risk score for prediction of heart failure: the Rotterdam Study

Arshi, B., van den Berge, J. C., van Dijk, B., Deckers, J. W., Ikram, M. A., & Kavousi, M. (2021) · BMC Medicine · doi:10.1186/s12916-021-01916-7 · Cited by 14

Left ventricular ejection fraction is associated with prevalent and incident cardiovascular disease in patients with intermittent claudication – results from the CAVASIC Study

Rantner, B., Pohlhammer, J., Stadler, M., Peric, S., Hammerer‐Lercher, A., Klein-Weigel, P. F., Fraedrich, G., Kronenberg, F., & Kollerits, B. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.060 · Cited by 14

Systolic time intervals revisited: correlations with N-terminal pro-brain natriuretic peptide in a community population

Cheng, H., Chuang, S., Hsu, P., Chou, P., & Chen, C. (2005) · Heart and Vessels · doi:10.1007/s00380-005-0844-6 · Cited by 14

The role and assessment of ventricular peptides in heart failure

Winter, W. E., & Elin, R. J. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.01.011 · Cited by 14

Stage B Heart Failure: Rationale for Screening

Atherton, J. J. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2011.11.003 · Cited by 13

Association of Health Aging and Body Composition (ABC) Heart Failure score with cardiac structural and functional abnormalities in young individuals

Gupta, S., Berry, J. D., Ayers, C. R., Matulevicius, S. A., Peshock, R. M., Patel, P. C., Markham, D. W., & Drazner, M. H. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.02.001 · Cited by 13

The Role of Natriuretic Peptides for the Diagnosis of Left Ventricular Dysfunction

Palazzuoli, A., Beltrami, M., Ruocco, G. M., Pellegrini, M., & Nuti, R. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/784670 · Cited by 13

Role of electrocardiography and echocardiography in prevention and predicting outcome of subjects at increased risk of heart failure

Bello, V. D., Carrubba, S. L., Antonini‐Canterin, F., Salvo, G. D., Caso, P., Canna, G. L., Erlicher, A., Badano, L. P., Romano, M. F., Zito, C., et al. (2013) · European Journal of Preventive Cardiology · doi:10.1177/2047487313508343 · Cited by 13

New and emerging biomarkers of heart failure

Clerico, A., Vittorini, S., Passino, C., & Emdin, M. (2009) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360902722342 · Cited by 13

Addition of Highly Sensitive Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Electrocardiography for Detection of Left Ventricular Hypertrophy

Martinez‐Rumayor, A., de Lemos, J. A., Rohatgi, A. K., Ayers, C. R., Powell‐Wiley, T. M., Gilchrist, S. C., Berry, J. D., Khera, A., & Das, S. R. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.195289 · Cited by 13

The past, the present, and the future of natriuretic peptides in the diagnosis of heart failure

Gaggin, H. K., & Januzzi, J. L. (2018) · European Heart Journal Supplements · doi:10.1093/eurheartj/suy024 · Cited by 13

Screening‐guided spironolactone treatment of subclinical left ventricular dysfunction for heart failure prevention in at‐risk patients

Potter, E. L., Stephenson, G., Harris, J., Wright, L. M., & Marwick, T. H. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2428 · Cited by 13

Cut-off values of B-type natriuretic peptide for the diagnosis of congestive heart failure in patients with dyspnoea visiting emergency departments: a study on Korean patients visiting emergency departments

Choi, S., Park, D., Lee, S. “., Hong, Y., Kim, S., & Lee, J. K. (2007) · Emergency Medicine Journal · doi:10.1136/emj.2006.041368 · Cited by 13

The Emerging Role of Echocardiography in the Screening of Patients at Risk of Heart Failure

Colonna, P., Pinto, F. J., Sorino, M., Bovenzi, F., D’Agostino, C., & de Luca, I. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.09.062 · Cited by 13

Heart failure in the elderly

Goodlin, S. J. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.1.99 · Cited by 13

Diagnostic accuracy of pre-operative NT-proBNP level in predicting short-term outcomes in coronary surgery: a pilot study.

Krzych, Ł. J., Szurlej, D., Kołodziej, T., Machej, L., Węglarzy, A., Błach, A., Wilczyński, M., Woś, S., & Bochenek, A. A. (2011) · PubMed · Cited by 13

Differential impact of antihypertensive drugs on cardiovascular remodeling: a review of findings and perspectives for HFpEF prevention

Takami, T., Hoshide, S., & Kario, K. (2021) · Hypertension Research · doi:10.1038/s41440-021-00771-6 · Cited by 12

Diagnostic Accuracy of Natriuretic Peptide Screening for Left Ventricular Systolic Dysfunction in the Community: Systematic Review and Meta-Analysis

Goyder, C., Roalfe, A. K., Jones, N. R., Taylor, K. S., Plumptre, C. D., James, O., Fanshawe, T. R., Hobbs, R. F., & Taylor, C. J. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14314 · Cited by 11

Natriuretic peptides: Ready for prime-time in hypertension?

Bricca, G., & Lantelme, P. (2011) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2011.04.004 · Cited by 12

Cyclin dependent kinase inhibitor 1 C is a female-specific marker of left ventricular function after acute myocardial infarction

Lalem, T., Zhang, L., Scholz, M. R., Burkhardt, R., Saccheti, V., Teren, A., Thiery, J., & Devaux, Y. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.07.042 · Cited by 12

Exercise impedance cardiography reveals impaired hemodynamic responses to exercise in hypertensives with dyspnea

Kurpaska, M., Krzesiński, P., Gielerak, G. G., Uziębło‐Życzkowska, B., Banak, M., Stańczyk, A., & Piotrowicz, K. (2018) · Hypertension Research · doi:10.1038/s41440-018-0145-y · Cited by 12

Relation of Plasma Midregional Proatrial Natriuretic Peptide to Target Organ Damage in Adults With Systemic Hypertension

Khaleghi, M., Al-Omari, M. A., Kondragunta, V., Morgenthaler, N. G., Struck, J., Bergmann, A., Mosley, T. H., & Kullo, I. J. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.01.012 · Cited by 12

Value of BNP to Estimate Cardiac Risk in Patients on Cardioactive Treatment in Primary Care

Nielsen, O. W., Cowburn, P., Sajadieh, A., Morton, J. J., Dargie, H., & McDonagh, T. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.10.004 · Cited by 12

The new epidemiology of heart failure

Rodeheffer, R. J. (2003) · Current Cardiology Reports · doi:10.1007/s11886-003-0046-8 · Cited by 12

Comparative sensitivities betweendifferent plasma B-type natriuretic peptide assays in patients with minimally symptomatic heart failure

Tang, W. H. W., Philip, K. J., Hazen, S. L., Stevenson, C., Pepoy, M. L., Neale, S., Francis, G. S., Lente, F. V., Smith, A. M., & Wu, A. H. B. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80010-9 · Cited by 12

Use of NT‐proBNP for the screening, diagnosis and risk‐stratification of left ventricular dysfunction

Jhund, P. S. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16388 · Cited by 13

Prevalence of Asymptomatic Left Ventricular Systolic Dysfunction in At-risk Medical Inpatients

Martin, L. D., Mathews, S. C., Ziegelstein, R. C., Martire, C., Howell, E. E., Hellmann, D. B., & Hirsch, G. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.06.020 · Cited by 11

Natriuretic peptides and the Framingham Risk score for screening of asymptomatic left ventricular systolic dysfunction in high-risk patients in primary care. The DAVID-BERG study

Iacovoni, A., Maria, R. D., Gavazzi, A., Grosu, A., Fontana, A., Guideri, S., Gori, M., Ferrari, P., Filippi, A., Rutili, M. R., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.260 · Cited by 11

Usefulness of B-type Natriuretic Peptide (BNP) as a screen for left ventricular abnormalities in diabetes mellitus

Cosson, S. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70132-5 · Cited by 11

Brain natriuretic peptide in Chagas' disease: further insights

Ribeiro, A. L. P., dos Reis, A. M., Teixeira, M. M., & Rocha, M. O. D. C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13990-6 · Cited by 11

Elevated Brain Natriuretic Peptide and High Brachial Pulse Pressure in Patients With Diabetes

Dillinger, J., Patin, C., Bonnin, P., Vidal-Trécan, T., Paven, E., Gautier, J., Riveline, J., Amah, G., & Henry, P. (2021) · American Journal of Hypertension · doi:10.1093/ajh/hpab179 · Cited by 10

Biomarkers in heart failure: a focus on natriuretic peptides

Eltayeb, M. M., Squire, I. B., & Sze, S. (2023) · Heart · doi:10.1136/heartjnl-2020-318553 · Cited by 13

Validez y utilidad del péptido ventricular natriurético tipo B (BNP) en la detección de disfunción ventricular izquierda en pacientes de alto riesgo en atención primaria

Bejarano, J. M. L., García, C. H., González‐González, A. I., Rodríguez, Á. C., Sánchez, S. D., Maroto, J. C., Rodríguez-Barrientos, R., & Fernández, M. Á. G. (2011) · Atención Primaria · doi:10.1016/j.aprim.2010.12.009 · Cited by 10

Plasma B-type natriuretic peptide is a useful tool for assessing coronary heart disease risk in a Japanese general population

Hasegawa, T., Asakura, M., Eguchi, K., Asanuma, H., Ohara, T., Kanzaki, H., Hashimura, K., Tomoike, H., Kim, J., & Kitakaze, M. (2014) · Hypertension Research · doi:10.1038/hr.2014.123 · Cited by 10

N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs

Геннадьевна, К. И., Novikova, D. S., Попкова, Т. В., Aleksandrova, E. N., Novikov, A. A., Gorbunova, Y. N., Markelova, E. I., Korsakova, Y. O., Glukhova, S. I., Volkov, A. V., et al. (2016) · Terapevticheskii arkhiv · doi:10.17116/terarkh201688519-26 · Cited by 10

Screening and Treatment for Subclinical Hypertensive Heart Disease in Emergency Department Patients With Uncontrolled Blood Pressure: A Cost‐effectiveness Analysis

Twiner, M. J., Marinica, A. L., Kuper, K., Goodman, A. C., Mahn, J. J., Burla, M. J., Brody, A., Carroll, J. A., Willock, R. J., Flack, J. M., et al. (2017) · Academic Emergency Medicine · doi:10.1111/acem.13122 · Cited by 10

Lower B-Type Natriuretic Peptide Levels Predict Left Ventricular Concentric Remodelling and Insulin Resistance

Okamoto, C., Tsukamoto, O., Hasegawa, T., Hitsumoto, T., Matsuoka, K., Takashima, S., Amaki, M., Kanzaki, H., Izumi, C., Ito, S., et al. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13700 · Cited by 10

Early Identification of Asymptomatic Subjects at Increased Risk of Heart Failure and Cardiovascular Events: Progress and Future Directions

Coller, J. M., Campbell, D. J., Krum, H., & Prior, D. (2012) · Heart Lung and Circulation · doi:10.1016/j.hlc.2012.09.009 · Cited by 10

Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction

Goetze, J. P., Møgelvang, R., Maage, L., Scharling, H., Schnohr, P., Søgaard, P., Rehfeld, J. F., & Jensen, J. S. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl406 · Cited by 94

Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: Results from the Dallas Heart Study

de Lemos, J. A., McGuire, D. K., Khera, A., Das, S. R., Murphy, S. A., Omland, T., & Drazner, M. H. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.12.017 · Cited by 103

Identification of Previously Undiagnosed Left Ventricular Systolic Dysfunction: Community Screening Using Natriuretic Peptides and Electrocardiography

Ng, L. L., Loke, I. W., Davies, J. E., Khunti, K., Stone, M. A., Abrams, K. R., Chin, D. T., & Squire, I. B. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00154-5 · Cited by 54

Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides

Ng, L. L., Loke, I. W., Davies, J. E., Geeranavar, S., Khunti, K. K., Stone, M. A., Chin, D. T., & Squire, I. B. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.058 · Cited by 92

Abstract 18079: B-Type Natriuretic Peptide is a Screening Tool to Rule Out Subclinical Left Ventricular Geometry and Diastolic Dysfunction in a Community-Based Population

Hasegawa, T., Asakura, M., Kanzaki, H., Kim, J., Asanuma, H., Funada, A., Sugano, Y., Ohara, T., Anzai, T., & Kitakaze, M. (2013) · Circulation · doi:10.1161/circ.128.suppl_22.a18079